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Man is the only known definitive host of the tapeworm
Taenia solium and becomes a carrier by eating under-
cooked pork contaminated with “Cysticercus cellulosae”
(cysticerci). Pigs act as intermediate host and acquire
cysticercosis by ingestion of eggs or proglottids from
human feces, which develop into cysticerci within tissue
mostly without causing clinical symptoms in the host.
Cysticercosis occurs in man in a context of “Fecal peril”
by ingestion of egg-contaminated soil, water or vegeta-
tion or by auto-infestation. In theory separation of
swine from humans, good cooking practice and hygiene
should lead straightforwardly to the eradication of the
disease! However cysticercosis is still a major public
health problem in endemic regions with more than 50
million infected people and is now a re-emerging disease
in industrialized countries due to human migration. It is
also the second cause of seizure in tropical countries. So
what are the pitfalls in cysticercosis control and what
can we do?
Cysticercosis affects free roaming pigs with access to
sites contaminated with human feces. Development of
good rearing practice guides will be of major impact.
Only few tools are available for ante-mortem diagnosis
of porcine cysticercosis and tongue palpation remains
the most commonly used tool. Therefore, the develop-
ment of a rapid diagnostic test, usable in villages, to test
cattle will be the second weapon. However, this will
need recombinant antigens. Diagnostic obstacles also
affect human patients presenting with seizures. Scans
and biological tests are not readily available leading to
the repeated treatment of patients.
New target proteins are thus needed to develop these
tests. With the sequencing of T. solium genome which
will allow identification and production of recombinant
protein a new step in the right direction was made.
Now a large advocacy to raise funds in order to get this
strategy on track is needed. Here we summarize the cur-
rent state of the disease, practical issues linked to the
organization of a feasible control system in developing
countries and new data available all over the world and
in particular in Madagascar to sustain this advocacy.
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